Corneal Densitometry in Type 2 Diabetes Patients: New Study Findings

Strategic Insights -

A new study examining the effects of type 2 diabetes on corneal densitometry has been conducted by researchers at the Ankara Bilkent City Hospital in Turkey. The study, published in the journal BMC Ophthalmology, aimed to analyze corneal densitometry values in individuals diagnosed with type 2 diabetes mellitus and compare them with those from a control group of healthy individuals.

Key Takeaways:

  • The study included 74 eyes of 37 patients diagnosed with type 2 diabetes mellitus (DM) and 54 eyes of 27 healthy volunteers matched for age and gender.
  • The research used the Pentacam Scheimpflug imaging system to measure corneal parameters, including flat keratometry (K1), steep keratometry (K2), maximum keratometry (Kmax), central corneal thickness (CCT), thinnest corneal thickness (TCT), average anterior and posterior elevation at the corneal apex (AAE and APE), corneal volume (CV), and corneal densitometry (CD).
  • The study found significant differences in corneal densitometry values between patients with type 2 DM and healthy controls, with patients with type 2 DM showing higher CD values.
  • The research concluded that chronic hyperglycemia may lead to both morphological and functional changes in the corneal tissue.
  • The study was conducted using SPSS software version 22.0, and the results were statistically analyzed using a controlled cross-sectional study design.

Statistics:

  • 74 eyes of 37 patients diagnosed with type 2 DM were included in the study.
  • 54 eyes of 27 healthy volunteers were used as a control group.
  • The study measured corneal parameters in detail according to radial zones (0-2 mm, 2-6 mm, 6-10 mm, 10-12 mm) and corneal depths (anterior, central, posterior, and total).
  • The study found that patients with type 2 DM had significantly higher CD values than healthy controls.
  • The p-value for the differences in CD values between patients with type 2 DM and healthy controls was less than 0.05.

Sources:

  • Evaluation of corneal densitometry using Pentacam in patients with type 2 diabetes mellitus: a controlled cross-sectional study. BMC Ophthalmology, 2025;25(1):558.
  • Bmc, Campus, 4 Crinan St, London N1 9XW, England. (BioMed Central - www.biomedcentral.com/; BMC Ophthalmology - www.biomedcentral.com/bmcophthalmol/)